Shares of Molecular Insight Pharmaceuticals, Inc.
(NASDAQ:MIPI) skyrocketed 64.94% to $1.27 after it presented positive data
from Phase 1 clinical studies comparing Trofex (123I-MIP-1072), its lead
molecular imaging candidate for the diagnosis and monitoring of metastatic
prostate cancer, and ProstaScint (111In-capromab pendetide), an imaging
radiopharmaceutical for the visualization of metastatic prostate cancer.
The 52-week
range of the stock is $0.70-$6.50. The stock went down more than 47%
year-to-date.
First Horizon National Corporation (NYSE:FHN) plunged 7.90%
to $10.03 on hefty volumes. The company said that it earned $16 million, or 7
cents a share, in the third quarter. In last year’s third quarter the Memphis,
Tenn., financial-services provider lost 23 cents a share.
Analysts
polled by FactSet Research estimated, on average, a loss of 3 cents a share.
Canadian Solar Inc. (NASDAQ:CSIQ) lost 7.08%
to $15.48 on about 2.90 million shares. Earlier this month, the Company has
appointed Andrew Chen as Chief Financial Officer effective immediately.
The 52-week
range of the stock is $8.99-$33.68. At today`s closing market price, the market
capitalization of the company stood at $661.70 million.
Joe's Jeans Inc. (NASDAQ:JOEZ) went down 6.57% to $1.85 on
strong volumes. Earlier this week, the company announced financial results for
the third quarter ended August 31, 2010. For the third quarter ended August 31,
2010, overall net sales were $25.5 million compared to $21.2 million from the
prior year comparative period, or a 20% increase.
In the past
one month of trading sessions, the stock went down more than 15%.
About Penny Stock Pick Report Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on top stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.